tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
PRQR is currently covered by 6 analysts with an average price target of $9.88. This is a potential upside of $7.12 (257.97%) from yesterday's end of day stock price of $2.76.
ProQR Therapeutics BV's activity chart (see below) currently has 22 price targets and 39 ratings on display. The stock rating distribution of PRQR is 84.21% BUY and 15.79% HOLD.
Analysts average stock forecasts to be materialized ratio is 40.74% with an average time for these price targets to be met of 170 days.
Highest price target for PRQR is $14, Lowest price target is $2, average price target is $9.88.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 12-Dec-2024. First documented stock forecast 26-Sep-2017.
Currently out of the existing stock ratings of PRQR, 16 are a BUY (84.21%), 3 are a HOLD (15.79%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4
$1.24 (44.93%)
$2.5
23 days ago
(12-Dec-2024)
5/6 (83.33%)
$0.62 (18.34%)
159
Buy
$10
$7.24 (262.32%)
$10
23 days ago
(12-Dec-2024)
3/10 (30%)
$6.62 (195.86%)
441
Buy
$8
$5.24 (189.86%)
$6
23 days ago
(12-Dec-2024)
0/3 (0%)
$4.62 (136.69%)
Buy
$14
$11.24 (407.25%)
$4
2 months 6 days ago
(29-Oct-2024)
2/5 (40%)
$10.55 (305.80%)
238
Hold
$2
$-0.76 (-27.54%)
$1.8
8 months 17 days ago
(18-Apr-2024)
4/5 (80%)
$0.14 (7.53%)
23
What is PRQR (ProQR Therapeutics BV) average time for price targets to be met?
Which analyst has the current highest performing score on PRQR (ProQR Therapeutics BV) with a proven track record?
Which analyst has the current lower performing score on PRQR (ProQR Therapeutics BV) with a proven track record?
Which analyst has the most public recommendations on PRQR (ProQR Therapeutics BV)?
Which analyst is the currently most bullish on PRQR (ProQR Therapeutics BV)?
Which analyst is the currently most reserved on PRQR (ProQR Therapeutics BV)?
